The McLean IRB meet on Wednesday to review the MDMA/cancer anxiety study. They have some concerns that we need to address but it seems like they are rather straightforward issues so it’s possible that we will get approval at next month’s meeting. If so, then we will start seeking the rest of the approvals (from an IRB at the Lahey clinic where the oncologist works and where the subjects will come from, FDA and DEA).